As of April 2024 Altimmune has a market cap of $0.50 Billion. This makes Altimmune the world's 5964th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.50 B | -16.96% |
2023 | $0.60 B | -25.25% |
2022 | $0.80 B | 122.16% |
2021 | $0.36 B | -13.12% |
2020 | $0.41 B | 1347.73% |
2019 | $28.93 M | 54.75% |
2018 | $18.7 M | -39.96% |
2017 | $31.14 M | -85.64% |
2016 | $0.21 B | 77.29% |
2015 | $0.12 B | 6.26% |
2014 | $0.11 B | 18.33% |
2013 | $97.28 M | 79.64% |
2012 | $54.15 M | -11.68% |
2011 | $61.31 M | -68.65% |
2010 | $0.19 B | 254.76% |
2009 | $55.13 M | -7.4% |
2008 | $59.54 M | -31.75% |
2007 | $87.24 M | 1.07% |
2006 | $86.32 M | 4.07% |
2005 | $82.94 M |
On Apr 24th, 2024 the market cap of Altimmune was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.85 B | 70.80% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $20.9 M | -95.84% | ๐บ๐ธ USA |